GlassScriptPrepare for your visit
Sommer Rae Kaskowitz
Family · Los Angeles, CA · NPI 1144620402
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$445.55
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 6 by amount.
- Teva Pharmaceuticals USA, INC. $264.75
- Janssen Pharmaceuticals, INC $50.93
- Glaxosmithkline, LLC. $29.95
- Alkermes, INC. $29.42
- Neurocrine Biosciences, INC. $29.11
- Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $28.02
Drugs and devices associated with these payments
Austedo Xr Aristada Invega Trinza Invega Sustenna Lybalvi Caplyta Accrufer
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Sommer Kaskowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11097752/sommer-rae-kaskowitz